Teladoc Health (TDOC) Short-term Investments (2015 - 2022)

Teladoc Health has disclosed Short-term Investments across 8 years of filings, most recently posting $2.5 million for Q2 2022.

• Short-term Investments for Q2 2022 came in at $2.5 million, changed 0.04% year-over-year; the trailing twelve-month figure through Jun 2022 was $2.5 million (changed 0.04% YoY), and the FY2021 annual result was $2.5 million, down 95.24% from the prior year.
• Short-term Investments came in at $2.5 million for Q2 2022 at Teladoc Health, roughly flat from $2.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $54.6 million in Q1 2018 to a low of $2.5 million in Q1 2021.
• The 5-year median for Short-term Investments is $3.1 million (2020), against an average of $18.9 million.
• Across the five-year window, Short-term Investments surged 1864.04% in 2020 and slumped 95.24% in 2021, its largest moves.
• Teladoc Health's Short-term Investments stood at $54.5 million in 2018, then tumbled by 95.03% to $2.7 million in 2019, then soared by 1864.04% to $53.2 million in 2020, then plunged by 95.24% to $2.5 million in 2021, then grew by 0.08% to $2.5 million in 2022.
• The last three Short-term Investments figures came in at $2.5 million (Q2 2022), $2.5 million (Q1 2022), and $2.5 million (Q4 2021), per Business Quant data.